Takara Bio Inc - ESG Rating & Company Profile powered by AI
The page includes a Q&A section on Takara Bio Inc. Other companies in the rating peer group for Takara Bio Inc are displayed below. This Disclosure rating includes 17 UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Takara Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.2; made up of an environmental score of 8.0, social score of 6.9 and governance score of 6.7.
7.2
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 191 | Wockhardt Ltd | 7.3 | High |
| 191 | Zealand Pharma A/S | 7.3 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Eurofins Scientific SE | 7.2 | High |
| 217 | Dermapharm Holding SE | 7.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Takara Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Takara Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Takara Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes Takara Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Takara Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Takara Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Takara Bio Inc offer flexible work?
Sign up for free to unlockDoes Takara Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Takara Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Takara Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes Takara Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Takara Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Takara Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Takara Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Takara Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Takara Bio Inc disclose water use targets?
Sign up for free to unlockDoes Takara Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Takara Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Takara Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Takara Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Takara Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Takara Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Takara Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Takara Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Takara Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Takara Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Takara Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Takara Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Takara Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Takara Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Takara Bio Inc disclose its waste policy?
Sign up for free to unlockDoes Takara Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Takara Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Takara Bio Inc disclose energy use targets?
Sign up for free to unlockDoes Takara Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Takara Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Takara Bio Inc
These potential risks are based on the size, segment and geographies of the company.
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company operates through Bioindustry and Gene Therapy segments. It develops research reagents and scientific instruments; and provides contract development and manufacturing organization (CDMO) services for academic and corporate life sciences research and development. The company's CDMO services include contract service for developing regenerative medicine products; related services, such as quality and safety testing, and cell banking; and contract services for supporting genetic analysis and testing comprising human genome sequence analysis, analysis of cancerrelated genes, and intestinal flora analysis, as well as support services for genetic engineering research, such as genome editing using the latest technologies and equipment. It also engages in the development and commercialization of various gene therapies, including oncolytic virus utilizing Canerpaturev, which is an attenuated strain of the herpes simplex virus type 1 that exhibits antitumor activity upon local injection into a tumor due to tumor lysis; siTCR gene therapy, which is in Phase I/II clinical trials for the treatment of synovial sarcoma; and CD19 chimeric antigen receptors that is in Phase I/II clinical trial for the treatment of adult acute lymphoblastic leukemia. Additionally, the company offers RetroNectin for gene therapy. The company was founded in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.